Northera

Lundbeck Completes Acquisition of Chelsea Therapeutics; NORTHERA™ (droxidopa) is expected to be available to patients in the U.S. during the fall of this year
Yahoo
Tue, 06/24/14 - 10:26 am
Lundbeck
Chelsea Therapeutics
Northera
neurogenic orthostatic hypotension
Better Buyout Candidate: Chelsea Therapeutics International Ltd. vs. InterMune Inc.
Motley Fool
Mon, 03/17/14 - 05:05 pm
Chelsea Therapeutics
Northera
Esbriet
idiopathic pulmonary fibrosis
InterMune
Chelsea Therapeutics Wins FDA Approval For Northera
TheStreet.com
Tue, 02/18/14 - 05:42 pm
FDA
Northera
Chelsea Therapeutics
neurogenic orthostatic hypotension
Chelsea Therapeutics: The Good, The Bad And The Ugly
Seeking Alpha
Thu, 02/13/14 - 09:12 am
Chelsea Therapeutics
FDA
Northera
Prediction: Chelsea Wins Northera FDA Approval Friday
TheStreet.com
Wed, 02/12/14 - 09:48 am
Chelsea Therapeutics
Northera
FDA
3 Companies Working on Parkinson's Treatments You Ought to Know About
Motley Fool
Wed, 01/29/14 - 05:42 pm
Parkinson's Disease
Chelsea Therapeutics
Prothena
Avanir
AVP-923
Northera
PRX-002
Chelsea Therapeutics May Be A Revenue Generating Biotech By The End Of 2014
Seeking Alpha
Fri, 01/17/14 - 08:36 am
Chelsea Therapeutics
Northera
Chelsea Wins U.S. Panel’s Backing for Northera
Bloomberg
Wed, 01/15/14 - 09:29 am
Chelsea Therapeutics
FDA
advisory panels
Northera
neurogenic orthostatic hypotension
Chelsea Therapeutics: Northera FDA Panel Live Blog
TheStreet.com
Tue, 01/14/14 - 09:09 am
FDA
advisory panels
Chelsea Therapeutics
Northera
neurogenic orthostatic hypotension
Shares of Chelsea Therapeutics Sink Ahead of FDA Review
Wall St Cheat Sheet
Sat, 01/11/14 - 08:01 am
Chelsea Therapeutics
Northera
FDA
Biotechs With Near-Term Catalysts That Should Rally
Seeking Alpha
Fri, 01/10/14 - 10:34 am
Ampio
Avanir
Chelsea Therapeutics
Endo Health Solutions
Optina
Northera
Synergy Pharmaceuticals
plecanatide
AVP-825
vintafolide
Long-term efficacy of Chelsea drug may pose problems for FDA
Yahoo/Reuters
Fri, 01/10/14 - 10:07 am
Chelsea Therapeutics
FDA
Northera
Droxidopa
neurogenic orthostatic hypotension
2 Biotech Stocks Facing Major Catalysts in 2014
Wall St Cheat Sheet
Tue, 12/3/13 - 09:23 am
Lion Biotechnologies
Chelsea Therapeutics
Northera
metastatic melanoma
Chelsea Therapeutics Minor NDA Deficiencies Create Opportunity For Huge Gains
Seeking Alpha
Tue, 08/27/13 - 09:34 am
Chelsea Therapeutics
Northera
Parkinson's Disease
Chelsea's NDA for Northera Accepted
Yahoo/Zacks
Sat, 07/20/13 - 11:09 am
Chelsea Therapeutics
Northera
neurogenic orthostatic hypotension
Chelsea Therapeutics shares sink after FDA recommends additional study for drug candidate
Yahoo/AP
Tue, 07/3/12 - 11:45 am
FDA
Northera
Chelsea Therapeutics
No Good News for Waiting Chelsea Investors
Motley Fool
Thu, 05/31/12 - 06:09 pm
Chelsea Therapeutics
Northera
CH-4051
rheumatoid arthritis
What To Do With Chelsea After The FDA Snub
Seeking Alpha
Sat, 03/31/12 - 11:53 am
Chelsea Therapeutics
Northera
neurogenic orthostatic hypotension
FDA rejects Chelsea's Northera, demands additional study data
Fierce Biotech
Thu, 03/29/12 - 10:26 am
FDA
Northera
Chelsea Therapeutics
neurogenic orthostatic hypotension
Five Reasons Chelsea Therapeutics' Northera Will Get FDA Approval
TheStreet.com
Mon, 02/27/12 - 11:09 am
Chelsea Therapeutics
Northera
FDA

Pages